Topic / Pathology
- ACT4ALS-MND
- Phase 2
- ALS
Objectives
To compare the efficacy of VHB937 vs. placebo on a composite of permanent assisted ventilation (PAV) free survival and function in Double Blind epoch
Learn more about : https://clinicaltrials.gov/study/NCT06643481
Sponsor
NOVARTIS
Investigator
French Coordinator : Prof Gaëlle Bruneteau
Scientific publication(s)
Status
Interrupted